| Q35059443 | A certified plasmid reference material for the standardisation of BCR-ABL1 mRNA quantification by real-time quantitative PCR |
| Q41312327 | A longitudinal evaluation of performance of automated BCR-ABL1 quantitation using cartridge-based detection system |
| Q54940104 | A multicenter round robin test of PD-L1 expression assessment in urothelial bladder cancer by immunohistochemistry and RT-qPCR with emphasis on prognosis prediction after radical cystectomy. |
| Q64064742 | A new highly sensitive real-time quantitative-PCR method for detection of BCR-ABL1 to monitor minimal residual disease in chronic myeloid leukemia after discontinuation of imatinib |
| Q40202920 | Accurate quantitation of JAK2 V617F allele burden by array-based digital PCR. |
| Q37000029 | An international comparability study on quantification of mRNA gene expression ratios: CCQM-P103.1. |
| Q36884361 | Best Practices in Chronic Myeloid Leukemia Monitoring and Management |
| Q26771228 | Deep Response in Multiple Myeloma: A Critical Review |
| Q26745594 | Deep molecular responses for treatment-free remission in chronic myeloid leukemia |
| Q89359928 | Development and evaluation of armored RNA-based standards for quantification of BCR-ABL1p210/p190 fusion gene transcripts |
| Q35603605 | Laboratory recommendations for scoring deep molecular responses following treatment for chronic myeloid leukemia. |
| Q38382105 | Leukemia research in Germany: the Competence Network Acute and Chronic Leukemias |
| Q52992928 | Measurement of BCR-ABL1 transcripts on the International Scale in the United States: current status and best practices. |
| Q38220970 | Minimal residual disease testing in hematologic malignancies and solid cancer |
| Q38176284 | Molecular monitoring |
| Q39027724 | Molecular monitoring in chronic myeloid leukemia-how low can you go? |
| Q38392702 | Molecular monitoring of chronic myeloid leukemia: principles and interlaboratory standardization |
| Q37696776 | Molecular techniques for the personalised management of patients with chronic myeloid leukaemia |
| Q95642294 | Monitoring of Minimal Residual Disease (MRD) in Chronic Myeloid Leukemia: Recent Advances |
| Q37478847 | Optimization of PCR for quantification of simian immunodeficiency virus genomic RNA in plasma of rhesus macaques (Macaca mulatta) using armored RNA |
| Q38762631 | Present and future of molecular monitoring in chronic myeloid leukaemia |
| Q54354157 | Sustained complete molecular remission after imatinib discontinuation in children with chronic myeloid leukemia. |